This program will provide an array of background and clinical information concerning the pharmacological use of buprenorphine for the treatment of opioid use disorder. 

At the conclusion of this activity participants should be able to:

• Screen and identify patients with OUD and define evidence-based treatments.
• Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients.
• Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient.
• Explain the process of buprenorphine induction as well as stabilization and maintenance.
• Discuss all FDA approved antagonist and agonist medications to treat OUD.
• Discuss basic office protocols including medical record documentation and confidentiality.
• Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD.